News
Hosted on MSN2mon
Globus Medical strengthens SCS market position with $250m Nevro dealGlobus Medical, which has a market cap of ... The company also sells sacroiliac joint fusion systems for lower back pain, technology it acquired after buying Vyrsa Technologies in 2023.
The Globus-M and now -M2 are primarily for scientific research and technology demonstration. They show the potential for spherical tokamaks to generate hybrid fusion-fission nuclear power.
With this approval, the Catamaran is now indicated to treat the SI joint as either a stand-alone treatment or to augment a spinal fusion. "The FDA has cleared the Catamaran SI Joint Fusion System ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results